Skip to content

A real world study for the efficacy and safety of Cinitapride in the treatment of functional dyspepsia

A real world study for the efficacy and safety of Cinitapride in the treatment of functional dyspepsia

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030949
Enrollment
Unknown
Registered
2020-03-19
Start date
2019-03-01
Completion date
Unknown
Last updated
2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

functional dyspepsia

Interventions

Case series:Cinitapride

Sponsors

Shanghai Ruijin Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The Rome IV standard for functional dyspepsia was used. That is, one or more of the four symptoms, i.e. post meal fullness discomfort, early satiety discomfort, upper and middle abdominal pain, upper and middle abdominal burning discomfort, and there is no evidence of structural diseases that can explain the above symptoms. Before diagnosis, the symptoms appear for at least six months, and nearly three months meet the above diagnostic criteria.

Exclusion criteria

Exclusion criteria: The patients with gastric and duodenal ulcer, mucosal erosion and bleeding under gastroscope, psychosis, mental and language disorders, hypersensitivity to the drug ingredients of the preparation, and other conditions that may reduce the possibility or complicate the enrollment according to the judgment of the researchers, such as frequent changes in the working environment, are likely to cause lost visits.

Design outcomes

Primary

MeasureTime frame
Total symptom improvement efficiency;Percentage change in total symptom score of functional dyspepsia;Change percentage of single symptom score compared with that before treatment;Percentage change of SF-36 score compared with that before treatment;Effects of various factors (such as diet habit, age, gender, HP infection) on the symptoms of functional dyspepsia and overlap in different regions of China;

Countries

China

Contacts

Public ContactDuowu Zou

Department of Gastroenterology, Ruijin Hospital

zdw_pi@126.com+86 13901617608

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026